Trial intelligence / Profile preview

Pyrotinib as neoadjuvant treatment for HER2-positive breast cancer

ChiCTR2100052892Phase 4Recruiting

Sponsor

First People's Hospital of Lianyungang City

Start

Jul 2021

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1